SUBSCRIBE
SUBSCRIBE
News   Business

Valeant Announces Second-Quarter 2017 Results

August 8, 2017 | 
1 min read
LAVAL, Quebec, Aug. 8, 2017 /PRNewswire/ --

Second-Quarter 2017 Financial Results

Revenues of $2.233 Billion

GAAP Net Loss of $38 Million
Earnings
Valeant Pharmaceuticals International
MORE ON THIS TOPIC
Novo Nordisk's logo on the facade of its building in Germany
Earnings
Novo Vows Smoother Market Waters for Wegovy—but Analysts Are Skeptical
May 7, 2025
 · 
2 min read
 · 
Tristan Manalac
3d rendering of a plastic jar with medical pills on a hand truck on blue background. Medicine and health. Bottles and containers. Healthcare industry.
Manufacturing
Amid Trump’s Trade War, Some Drugmakers Stockpile Products in U.S.
May 7, 2025
 · 
2 min read
 · 
Tristan Manalac
Podcast
Trump’s US Manufacturing Push, New Vaccine Policy, Novo’s Weight Loss Pill up for FDA Review
May 7, 2025
 · 
1 min read
 · 
Heather McKenzie
Steel Hammer,eps 8, all elemnts are in seperate layers and grouped. Please visit my portfolio for more options.
Manufacturing
Trump Orders FDA To Ease US Plant Expansion; Drops Hammer on Foreign Inspections
May 6, 2025
 · 
3 min read
 · 
Annalee Armstrong